{"id":"9c75b380-8657-4f59-ba05-55e438eea7a9","name":"Abbott","slug":"abbott","description":"US healthcare and medical-device company (NYSE: ABT) whose Abbott Diabetes Care unit makes Lingo, an over-the-counter continuous glucose monitor for non-diabetic / wellness consumers built on the FreeStyle Libre platform (FDA 510(k) K233655, OTC, adults 18+ not on insulin).","status":"public (NYSE: ABT)","founded":1888,"hq":"Abbott Park, Illinois, USA","fundingTotal":null,"type":"both","reviewStatus":"reviewed","sources":[{"url":"https://abbott.mediaroom.com/2024-06-10-Abbott-Receives-FDA-Clearance-for-Two-Over-the-Counter-Continuous-Glucose-Monitoring-Systems","title":"Abbott receives FDA clearance for two OTC CGM systems (Lingo + Libre Rio; FDA 510(k) K233655 decided May 29 2024; adults 18+ not on insulin)","sourceName":"Abbott (newsroom)"},{"url":"https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K233655","title":"FDA 510(k) K233655: OTC integrated continuous glucose monitoring system (Class II, 21 CFR 862.1355; adults 18+ not on insulin; not for diagnosis of any disease)","sourceName":"FDA 510(k) database"},{"url":"https://www.hellolingo.com/","title":"Lingo biosensor + app (Lingo Count adaptive metric, personalized recommendations, Lingo Challenges; 14-day biosensor; entry $54 / 2-week plan; Lingo Live = human nutritionist sessions)","sourceName":"Abbott / Lingo (official)"}],"keyFacts":[{"label":"Product","value":"Lingo OTC glucose biosensor (FDA 510(k) K233655, May 2024) + adaptive insight app (Lingo Count); built on FreeStyle Libre."},{"label":"Boundary","value":"Glucose-biometric + adaptive insight -> narrow INCLUDE; AI is adaptive/algorithmic, NOT generative (not at Stelo parity)."}],"aliases":["Abbott Laboratories","Abbott Diabetes Care","Lingo"],"collisionRisk":"low","reviewNote":null,"createdAt":"2026-06-03T23:33:06.188Z","updatedAt":"2026-06-03T23:33:06.188Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/abbott","url":"https://registry.deploy.report/companies/abbott","name":"Abbott","alternateName":["Abbott Laboratories","Abbott Diabetes Care","Lingo"],"description":"US healthcare and medical-device company (NYSE: ABT) whose Abbott Diabetes Care unit makes Lingo, an over-the-counter continuous glucose monitor for non-diabetic / wellness consumers built on the FreeStyle Libre platform (FDA 510(k) K233655, OTC, adults 18+ not on insulin).","identifier":"9c75b380-8657-4f59-ba05-55e438eea7a9","foundingDate":"1888","address":"Abbott Park, Illinois, USA","publisher":{"@id":"https://deploy.report/#organization"}}}